Chiesi Farmaceutici S.p.A.

Chiesi Farmaceutici S.p.A.

200px

Type	Private
Key people	Alberto Chiesi (Chairman), Ugo Di Francesco (CEO)
Industry	Pharmaceuticals
Products	Pharmaceuticals
Revenue	€2.4 billion (2022)
Employees	6,000 (2022)
Website	[www.chiesi.com Official website]

Chiesi Farmaceutici S.p.A. is a multinational pharmaceutical company headquartered in Parma, Italy. Founded in 1935 by Giulio Chiesi, the company has grown to become a significant player in the global pharmaceutical industry, focusing on the research, development, and commercialization of innovative therapeutic solutions.

History

Chiesi Farmaceutici was established in 1935 by Giulio Chiesi, a pharmacist, in Parma, Italy. Initially, the company focused on producing and distributing pharmaceutical products within Italy. Over the decades, Chiesi expanded its operations internationally, establishing subsidiaries and research centers across Europe, the Americas, and Asia.

In the 1970s, Chiesi began investing heavily in research and development, which led to the creation of several innovative products in the fields of respiratory, neonatology, and rare diseases. The company's commitment to R&D has been a cornerstone of its growth strategy, with significant investments made annually to support new drug development.

Research and Development

Chiesi Farmaceutici is renowned for its strong emphasis on research and development (R&D). The company operates several R&D centers worldwide, employing over 1,000 researchers dedicated to discovering and developing new therapeutic solutions. Chiesi's R&D efforts are primarily focused on three main areas:

• Respiratory Diseases: Chiesi has developed a range of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD), including innovative inhalation devices.
• Neonatology: The company is a leader in the development of treatments for premature infants, particularly in the area of respiratory distress syndrome (RDS).
• Rare Diseases: Chiesi is committed to addressing unmet medical needs in the field of rare diseases, with several products in development and on the market.

Global Presence

Chiesi Farmaceutici operates in over 30 countries, with a strong presence in Europe, North America, and Asia. The company has manufacturing facilities in Italy, France, and Brazil, and its products are distributed in more than 80 countries worldwide.

Sustainability and Corporate Social Responsibility

Chiesi is committed to sustainability and corporate social responsibility (CSR). The company has implemented various initiatives to reduce its environmental impact, promote ethical business practices, and support community health programs. Chiesi is also a certified B Corporation, reflecting its commitment to balancing profit with purpose.

Also see

• Pharmaceutical industry
• Research and development
• Asthma
• Chronic obstructive pulmonary disease
• Rare diseases